Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-07-19
2011-07-19
Hartley, Michael G (Department: 1618)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S277000, C514S352000, C514S852000, C514S861000, C514S863000, C514S864000, C514S881000, C546S290000, C546S294000, C546S295000, C546S300000, C546S301000, C546S302000
Reexamination Certificate
active
07981909
ABSTRACT:
Compounds of the formula (I) are disclosed and are suitable for the treatment of seborrheic dermatitis.
REFERENCES:
patent: 3883545 (1975-05-01), Lohaus et al.
patent: 3968118 (1976-07-01), Lohaus et al.
patent: 4172149 (1979-10-01), Pinto et al.
patent: 4185106 (1980-01-01), Dittmar et al.
patent: 4699924 (1987-10-01), Durrant et al.
patent: 4711775 (1987-12-01), Dittmar et al.
patent: 4797109 (1989-01-01), Wende
patent: 4797409 (1989-01-01), Lohaus et al.
patent: 4957730 (1990-09-01), Bohn et al.
patent: 5066484 (1991-11-01), Castrogiovanni et al.
patent: 5071639 (1991-12-01), Soyama
patent: 5120530 (1992-06-01), Ferro et al.
patent: 5132107 (1992-07-01), Lange
patent: 5264206 (1993-11-01), Bohn et al.
patent: 5346692 (1994-09-01), Wohlrab et al.
patent: 5356907 (1994-10-01), Clemence et al.
patent: 5395843 (1995-03-01), Clemence et al.
patent: 5494658 (1996-02-01), Hanel et al.
patent: 5510100 (1996-04-01), Picard et al.
patent: 5559130 (1996-09-01), Clemence et al.
patent: 5603939 (1997-02-01), Ser
patent: 5609854 (1997-03-01), Guerrero et al.
patent: 5612327 (1997-03-01), Makino et al.
patent: 5650145 (1997-07-01), Saint-Leger
patent: 5675013 (1997-10-01), Hani et al.
patent: 5683681 (1997-11-01), Ramin et al.
patent: 5753600 (1998-05-01), Kamegai et al.
patent: 5756108 (1998-05-01), Ribier et al.
patent: 5814322 (1998-09-01), Sebillotte-Arnaud
patent: 5866105 (1999-02-01), Richter et al.
patent: 6075017 (2000-06-01), Dascalu et al.
patent: 6120756 (2000-09-01), Markowitz
patent: 6162420 (2000-12-01), Bohn et al.
patent: 6455551 (2002-09-01), Kraemer et al.
patent: 6469033 (2002-10-01), Bohn et al.
patent: 6514490 (2003-02-01), Odds et al.
patent: 2003/0086881 (2003-05-01), Bohn et al.
patent: 2004/0039030 (2004-02-01), Bohn et al.
patent: 2004/0081677 (2004-04-01), Bohn et al.
patent: 716208 (1998-04-01), None
patent: 2134293 (1995-04-01), None
patent: 2134304 (1995-04-01), None
patent: 3140954 (1983-05-01), None
patent: 3826914 (1990-02-01), None
patent: 0117135 (1984-08-01), None
patent: 0218410 (1987-04-01), None
patent: 0241918 (1987-10-01), None
patent: 0312234 (1989-04-01), None
patent: 0313305 (1989-04-01), None
patent: 0315912 (1989-05-01), None
patent: 0381446 (1990-08-01), None
patent: 0515312 (1992-11-01), None
patent: 0646369 (1995-04-01), None
patent: 0649660 (1995-04-01), None
patent: 0680745 (1995-11-01), None
patent: 0771187 (1997-05-01), None
patent: 2618068 (1989-01-01), None
patent: 2685638 (1993-07-01), None
patent: 2685867 (1993-07-01), None
patent: 2694694 (1994-02-01), None
patent: 2722097 (1994-07-01), None
patent: 2180846 (1987-04-01), None
patent: 2207051 (1989-01-01), None
patent: 2208149 (1989-03-01), None
patent: 202098 (1990-03-01), None
patent: 208007 (1991-05-01), None
patent: 49-050142 (1974-05-01), None
patent: 56-065810 (1981-06-01), None
patent: 58-113299 (1983-07-01), None
patent: 61-69721 (1986-04-01), None
patent: 02-111713 (1990-04-01), None
patent: 06-080567 (1994-03-01), None
patent: 07-187968 (1995-07-01), None
patent: 08-048625 (1996-02-01), None
patent: 87-02580 (1987-05-01), None
patent: 88-00041 (1988-01-01), None
patent: 94-05256 (1994-03-01), None
patent: 95-17165 (1995-06-01), None
patent: 96-02226 (1996-02-01), None
patent: 96-13247 (1996-05-01), None
patent: 96-19186 (1996-06-01), None
patent: 96-29045 (1996-09-01), None
patent: 96-29056 (1996-09-01), None
patent: 97-20560 (1997-06-01), None
patent: 98-13042 (1998-04-01), None
patent: 98-13043 (1998-04-01), None
patent: 99-39680 (1999-08-01), None
patent: 99-49835 (1999-10-01), None
Hanel, H., Mycoses, 1991, 34, Suppl. 1, p. 91-93.
Arndt, “Seborrheic Dermatitis and Dandruff,” Manual of Dermatologic Therapeutics, Chapter 29, 1995, pp. 164-167.
Hanel et al., Therapy of seborrheic eczema with an antifungal agent with an antiphlogistic effect, (abstract only), Pubmed (Medline) PMID: 1840158, Mycoses, 1991, vol. 34, Suppl 1, pp. 91-93.
Buslau et al., The significance of yeasts in seborrheic eczema, (abastract only), Pubmed-Medline, PMID:2533189, Hautarzt, Oct. 1989; vol. 40(10), pp. 611-613.
Seborrheic Dermatitis, American Academy of Dermatology, pp. 1-4 (2003).
Board of Patent Appeals and Interferences Decision on Request for Rehearing dated Dec. 22, 2004 (Appeal No. 2004-0309), related to U.S. Appl. No. 09/077,194.
Consumer Medicine Information, http://medsafe.govt.nz/consumers/cmi/s/stieprox.htm,pp. 1-4,printed on Jul. 6, 2006.
Cyclomethicones,http://www.clearcoproducts.com/cyclomethicones.html, pp. 1-5,printed on Jul. 12, 2006.
Declaration of Steve Bradford dated Feb. 18, 2005.
Declaration of R. Todd Plott dated Jul. 17, 2006.
Derwent abstract No. 95-325488 for JP 07 223 971 A (Aug 22, 1995).
Derwent abstract of DE 3826914 A1, Feb. 15, 1990.
Derwent abstract of FR 2 618 068, Jan. 20, 1989.
Elewski et al., Continuing Medical Education, J. Amer. Acad. Dermatol. 21:655-73 (1989).
Examiner's Answer (to appeal brief) dated Apr. 9, 2003.
Helm, B. Wikipedia: A Work in Progress from Business Week Online available at http://www.businessweek.com/technology/content/dec2005/tc20051214—441708.htm?chan=db.
Interview Summary dated Oct. 1, 2002, from U.S. Appl. No. 09/077,194.
Japanese Abstract No. 07082126-A vol. 95, No. 003, Mar. 28, 1995.
Loprox Shampoo, MEDICIS, pp. 1-11 and prescribing information as of Feb. 2003.
Office Action dated Jun. 16, 1999, from U.S. Appl. No. 09/077,194.
Office Action dated Oct. 14, 1999, from Application U.S. Appl. No. 09/077,194.
Office Action dated Feb. 1, 2000, from U.S. Appl. No. 09/077,194.
Office Action dated Apr. 17, 2000, from U.S. Appl. No. 09/077,194.
Office Action dated Aug. 28, 2000, from U.S. Appl. No. 09/077,194.
Office Action dated Dec. 5, 2000, from U.S. Appl. No. 09/077,194.
Office Action dated Apr. 24, 2001, from U.S. Appl. No. 09/077,194.
Office Action dated Oct. 24, 2001, from U.S. Appl. No. 09/077,194.
Office Action dated Jul. 18, 2002, from U.S. Appl. No. 09/077,194.
Office Action dated Mar. 2, 2005, from U.S. Appl. No. 09/077,194.
Seborrheic Dermatitis from the Amer. Acad. Sci. available at http://www.aad.org/public/Publications/pamphlets/SeborrheicDermatitis.htm accessed Jul. 6, 2006.
Seigenthaler, J. A False Wikipedia biography from USA Today on line available at http://www.usatoday.com
ews/opinion/editorials/2005-11-29-wikipedia-edit—x.htm.
The Merck Index, An Encyclopedia of Chemicals, Drugs, and Biologicals, p. 1345 (2001).
Translation of Abstract of Grosshans et al. L'czema Seborrheique (La Pityrosporose) Ann. Dermatol Venereol. 115:79-86(1988).
Translation of EP 077 187, May 7, 1997.
Translation of FR 2 618 068, Jan. 20, 1989.
Translation of FR 2 685 867, Jul. 9, 1993.
Van Cutsem et al., Clinical and Laboratory Studies: The in vitro Antifungal Activity Ketoconazole, Zinc Pyrithione, and Selenium Sulfide Against Pityrosporum and Their Efficacy as a Shampoo in the treatment of Experimental Pityrosporosis in Guinea Pigs. J. Amer. Acad. Dermatol 22:993-98 (1990).
Seborrheic Dermatitis, American Academy of Dermatology, pp. 1-4 (2003).
The Merck Index, An Encyclopedia of Chemicals, Drugs, and Biologicals, p. 1345 (2001).
Abstracts of JP 06080567 A, published Mar. 22, 1994, to Koichi et al. (1) Patent Abstract AN 1994-080567 and (2) Chemical Abstract AN 1994:491796.
Abstracts of JP 08048625 A, published Feb. 20, 1996, to Akira et al. (1) Patent Abstract AN 1996-048625, and (2) Chemical Abstract AN 1996:262456.
Abstracts of JP 56065810 A, published Jun. 3, 1981, to Takashi et al. (1) Patent Abstract AN 1981-065810 and (2) Chemical Abstract AN 1981:520977.
Aly et al. Ciclopirox Gel for Seborrheic Dermatitis of the Scalp. Int. J. Dermatol. 42:19-22 (2003).
Consumer Medicine Information, http://medsafe.govt.nz/consumers/cmi/s/stieprox.htm, pp. 1-4, printed on Jul. 6, 2006.
Declaration of James Leyden, M.D., including Exhibits A-D, filed Jun. 26, 2003.
Declaration of R. Todd Plott dated Jul. 17, 2006.
Lynfield et al., Common skin problems in adolescents, (abstract only), International Journal of Adolescent Medicine and Health, 1985, vol. 1, No. 1-2, pp. 113-117.
English language summary of Schofer, H. Therap
Bohn Manfred
Kraemer Karl Theodor
Markus Astrid
Hartley Michael G
McNichol William J.
Medicis Pharmaceutical Corporation
Reed Smith LLP
Schlientz Leah
LandOfFree
Use of 1-hydroxy-2-pyridones for the treatment of seborrheic... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of 1-hydroxy-2-pyridones for the treatment of seborrheic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of 1-hydroxy-2-pyridones for the treatment of seborrheic... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2644233